Is Portage Biotech Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: PRTG) stock is to Buy PRTG stock.
Out of 1 analyst, 0 (0%) are recommending PRTG as a Strong Buy, 1 (100%) are recommending PRTG as a Buy, 0 (0%) are recommending PRTG as a Hold, 0 (0%) are recommending PRTG as a Sell, and 0 (0%) are recommending PRTG as a Strong Sell.
What is PRTG's forecast return on equity (ROE) for 2024-2026?
(NASDAQ: PRTG) forecast ROE is -189.75%, which is considered weak.
What is PRTG's Price Target?
According to 1 Wall Street analyst that have issued a 1 year PRTG price target, the average PRTG price target is $6.00, with the highest PRTG stock price forecast at $6.00 and the lowest PRTG stock price forecast at $6.00.
The Wall Street analyst predicted that Portage Biotech's share price could reach $6.00 by Nov 29, 2024. The average Portage Biotech stock price prediction forecasts a potential upside of 1,011.11% from the current PRTG share price of $0.54.
What is PRTG's forecast return on assets (ROA) for 2024-2026?
(NASDAQ: PRTG) forecast ROA is -123.83%, which is lower than the forecast US Biotechnology industry average of 4.45%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.